Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study

被引:2
|
作者
Mongraw-Chaffin, Morgana [1 ]
Saldana, Santiago [2 ]
Carnethon, Mercedes R. [3 ]
Chen, Haiying [2 ]
Effoe, Valery [4 ]
Golden, Sherita Hill [5 ]
Joseph, Joshua [6 ]
Kalyani, Rita R. [5 ]
Bertoni, Alain G. [1 ]
机构
[1] Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27157 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Morehouse Sch Med, Div Cardiol, Atlanta, GA 30310 USA
[5] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
关键词
type; 2; diabetes; metabolic syndrome; visceral fat normal weight; African American; BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; AFRICAN-AMERICANS; HEALTHY OBESITY; CONSEQUENCES; ACCUMULATION;
D O I
10.1210/jendso/bvac059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis. Objective: While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans. Methods: In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m(2)). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity. Results: Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D. Conclusion: Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes 2016
    Thounaojam, Menaka C.
    Nammi, Srinivas
    Jadeja, Ravirajsinh
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [22] Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes 2014
    Thounaojam, Menaka C.
    Nammi, Srinivas
    Jadeja, Ravirajsinh
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [23] Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications
    Mensah, GA
    Mokdad, AH
    Ford, E
    Narayan, KMV
    Giles, WH
    Vinicor, F
    Deedwania, PC
    CARDIOLOGY CLINICS, 2004, 22 (04) : 485 - 504
  • [24] Polymorphisms in Kalirin are associated with type 2 diabetes, metabolic syndrome and measures of cardiovascular risk in the diabetes heart study
    Rudock, Megan E.
    Ziegler, Julie T.
    Lehtinen, Allison B.
    Freedman, Barry I.
    Carr, J. J.
    Langefeld, Cardl D.
    Bowden, Donald W.
    DIABETES, 2008, 57 : A42 - A43
  • [25] Fasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study
    DeFina, Laura F.
    Vega, Gloria Lena
    Leonard, David
    Grundy, Scott M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (08) : 1164 - 1168
  • [26] Metabolic Surgery for Type 2 Diabetes and Obesity
    Al Salman, A.
    OBESITY SURGERY, 2013, 23 (08) : 1186 - 1186
  • [27] Obesity and Mortality: the Jackson Heart Study
    Min, Yuan-I
    Valle, Karen A.
    Anugu, Pramod
    Gao, Yan
    Anugu, Anshul
    Norwood, Arnita F.
    Correa, Adolfo
    CIRCULATION, 2019, 139
  • [28] Metabolic syndrome: Prevalence and association with cardiovascular diseases in the Jackson Heart Study
    Liu, Jiankang
    Taylor, Herman A., Jr.
    Crook, Errol D.
    Golden, Sherita H.
    Steffes, Michael W.
    Johnson, William B.
    Brunson, Claude D.
    Wilson, Gregory
    CIRCULATION, 2007, 115 (08) : E228 - E228
  • [29] Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study
    Yi Guo
    Solomon K. Musani
    Mario Sims
    Thomas A. Pearson
    Mark D. DeBoer
    Matthew J. Gurka
    Diabetology & Metabolic Syndrome, 10
  • [30] Metabolite Markers of Incident Type 2 Diabetes and Cardiovascular Disease in the Jackson Heart Study
    Chen, Zsu-Zsu
    Gao, Yan
    Cruz, Daniel E.
    Tahir, Usman
    Peterson, Bennet
    Robbins, Jeremy
    Benson, Mark
    Ngo, Debby
    Correa, Adolfo
    Clish, Clary
    Wilson, James
    Gerszten, Robert E.
    CIRCULATION, 2019, 140